title: Pharmaceutical industry and trade liberalization using computable general equilibrium model.
abstract: BACKGROUND
  Computable general equilibrium models are known as a powerful instrument in economic analyses and widely have been used in order to evaluate trade liberalization effects. The purpose of this study was to provide the impacts of trade openness on pharmaceutical industry using CGE model.
  
  
  METHODS
  Using a computable general equilibrium model in this study, the effects of decrease in tariffs as a symbol of trade liberalization on key variables of Iranian pharmaceutical products were studied. Simulation was performed via two scenarios in this study. The first scenario was the effect of decrease in tariffs of pharmaceutical products as 10, 30, 50, and 100 on key drug variables, and the second was the effect of decrease in other sectors except pharmaceutical products on vital and economic variables of pharmaceutical products. The required data were obtained and the model parameters were calibrated according to the social accounting matrix of Iran in 2006.
  
  
  RESULTS
  The results associated with simulation demonstrated that the first scenario has increased import, export, drug supply to markets and household consumption, while import, export, supply of product to market, and household consumption of pharmaceutical products would averagely decrease in the second scenario. Ultimately, society welfare would improve in all scenarios.
  
  
  CONCLUSIONS
  We presents and synthesizes the CGE model which could be used to analyze trade liberalization policy issue in developing countries (like Iran), and thus provides information that policymakers can use to improve the pharmacy economics.
authors: Dept. of Health Economics, School of Health Management and Information Sciences, Tehran University of Medical Sciences, Tehran, Iran.
authors: M
authors: M
authors: Barouni
authors: H
authors: H
authors: Ghaderi
authors: Aa
authors: A
authors: Banouei
keywords: Computable general equilibrium model; Pharmaceutical products; Tariff; Trade liberalization
references: J Health Econ. 2009 Jan;28(1):221-33
references: 19062116
references: Saudi Pharm J. 2012 Oct;20(4):323-30
references: 23960807
references: Iran J Pharm Res. 2017 Winter;16(1):1-7
references: 28496457